ADEQUAN POLYSULPHATED GLYCOSAMINOGLYCAN INJECTION 250MG/ML

Šalis: Australija

kalba: anglų

Šaltinis: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Veiklioji medžiaga:

GLYCOSAMINOGLYCAN POLYSULFATE

Prieinama:

ELANCO AUSTRALASIA PTY LTD

INN (Tarptautinis Pavadinimas):

glycosaminoglycan polysulfat(250mg/mL)

Vaisto forma:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Sudėtis:

GLYCOSAMINOGLYCAN POLYSULFATE EMULSIFIERS & SURFACTANTS Active 250.0 mg/ml

Vienetai pakuotėje:

5x1mL Amp

Klasė:

VM - Veterinary Medicine

Pagaminta:

ELANCO AUSTRALASIA

Farmakoterapinė grupė:

HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL

Gydymo sritis:

MUSCULOSKELETAL SYSTEM

Terapinės indikacijos:

DEGENERATIVE ASEPTIC JOINT DISEASE | TRAUMATIC DEGENERATIVE JOINT D

Produkto santrauka:

Poison schedule: 4; Withholding period: WHP: Meat: 28 days; Host/pest details: HORSE: [DEGENERATIVE ASEPTIC JOINT DISEASE]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [DEGENERATIVE ASEPTIC JOINT DISEASE]; An aid in the treatment of traumatic and degenerative aseptic joint disease in horses.

Autorizacija statusas:

Registered

Leidimo data:

2023-07-01

Pakuotės lapelis

,..
ADEQUAN IA
NRA 36012
PAGE 1 OF 4
8.5.2001
VIAL LABEL
(1
rnt)
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
ADEQUAN®
POLYSULPHATED GLYCOSAMINOGLYCAN INJECTION 250 mg/mL
BOEHRINGER
INGELHEIM
_---.....-0::----,.;
N.R.A.
I
APPROVED
LABEL
('TEXl')
\
Label
No:
.~iff.?'?:L~§:t?;··l
Date:
.Q.$."?!~
_..._
_¥P_
_..._
_\_
Sign~wrEl:
.,,:'..~/I~H;;.J
"..
ADEQUAN IA
NRA 36012
PAGE
20F
4
8.5.2001
CARTON LABEL
-
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
ADEQUAN®
POLSULPHATED GLYCOSAMINOGLYCAN INJECTION 250 mglmL
An aid in the treatment of traumatic and degenerative aseptic joint
disease in
horses
5 x 1 mL ampoules
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
DIRECTIONS FOR USE
Administer the contents of
1 ampoule
(1
mL) by intra-articular injection into
the affected joint once weekly for five weeks.
The joint area must
be shaved,
cleansed and sterilised prior to administration to prevent joint
infection.
MEAT WITHHOLDING PERIOD
2A/DAYS.
Disposal
Dispose of empty container by wrapping with paper and putting in
garbage.
Store below 25°C (air conditioning)
NRA
360121
Batch No.:
Expiry Date:
Boehringer
Ingelheim
Janssen Pharmaceutica
,..
ADEQUAN IA
NRA 36012
PAGE
30F
4
8.5.2001
PACKAGING INSERT
-
PRESCRIPTION ANIMAL REMEDY
KEEP
OUT
OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
ADEQUAN®
Polysulphated Glycosaminoglycan Injection 250 mglmL
INDICATION
Adequan" is for use as an aid in the treatment of traumatic and
degenerative
aseptic joint disease in horses.
In healthy cartilage the synthesis and degradation of cartilage is in
equilibrium.
In traumatic and degenerative joint
disease this balance is shifted
towards increasing degradation.
This results in a loss of
mucopolysaccharides which are the basic building blocks of cartilage.
The
destruction of joint cartilage progresses unless the process is
reversed.
Adsquan"
is similar to the mucopolysaccharides of cartilage and is
concentrated in cartilaginous tissue.
Adsquan"
exerts its activi